TheProfitWatch

PHIO - Phio Pharmaceuticals Corp. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
2.22 0.0 (0.0%) --- --- --- 0.0 (0.0%) -0.01 (-0.44%) 0.0 (0.0%) 0.0 (0.0%)

Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.45
Diluted EPS:
-0.45
Basic P/E:
-4.9333
Diluted P/E:
-4.9333
RSI(14) 1m:
0.0
VWAP:
2.22
RVol:
0.5044

Events

Period Kind Movement Occurred At
1m Price increase 1m 2.22 +0.03 (+1.35%) Oct 15 11:21
10m Price decrease 10m 2.16 -0.09 (-4.04%) Oct 15 09:32

Related News